...BioMarin (see BioCentury, Nov. 5, 2012). BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...designation in the U.S. and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...designation in the U.S. and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...designation in the U.S. and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...designation in the U.S. and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...designation in the U.S. and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...designation in the U.S. and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...in the U.S., EU and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...Firdapse (see BioCentury, Nov. 5, 2012). BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....

...in the U.S., EU and Switzerland. BioMarin gained the compound through its 2009 acquisition of Huxley Pharmaceuticals Inc....